том 17 издание 12 страницы 1-13

The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)

Pasquale Pagliano 1
Carmine Sellitto 2
Tiziana Ascione 3
Giuliana Scarpati 4
Veronica Folliero 5
Ornella Piazza 4
Gianluigi Franci 6
Amelia Filippelli 2
Valeria Conti 2
Тип публикацииJournal Article
Дата публикации2022-12-12
scimago Q1
wos Q1
БС1
SJR1.195
CiteScore10.6
Impact factor4.9
ISSN17460441, 1746045X
Найдено 
Найдено 

Топ-30

Журналы

1
Farmatsiya i Farmakologiya
1 публикация, 5.88%
Expert Opinion on Drug Discovery
1 публикация, 5.88%
Reproductive Toxicology
1 публикация, 5.88%
Mendeleev Communications
1 публикация, 5.88%
ACS Pharmacology & Translational Science
1 публикация, 5.88%
Expert Opinion on Drug Metabolism and Toxicology
1 публикация, 5.88%
Expert Opinion on Investigational Drugs
1 публикация, 5.88%
Bioorganic Chemistry
1 публикация, 5.88%
Russian Journal of General Chemistry
1 публикация, 5.88%
Antiviral Research
1 публикация, 5.88%
Molecules
1 публикация, 5.88%
Mutation Research - Reviews in Mutation Research
1 публикация, 5.88%
European Journal of Medicinal Chemistry
1 публикация, 5.88%
Toxicological Sciences
1 публикация, 5.88%
Computers in Biology and Medicine
1 публикация, 5.88%
Current Nutrition and Food Science
1 публикация, 5.88%
Journal of Materials Research
1 публикация, 5.88%
1

Издатели

1
2
3
4
5
6
Elsevier
6 публикаций, 35.29%
Taylor & Francis
3 публикации, 17.65%
Volgograd State Medical University
1 публикация, 5.88%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 публикация, 5.88%
American Chemical Society (ACS)
1 публикация, 5.88%
Pleiades Publishing
1 публикация, 5.88%
MDPI
1 публикация, 5.88%
Oxford University Press
1 публикация, 5.88%
Bentham Science Publishers Ltd.
1 публикация, 5.88%
Springer Nature
1 публикация, 5.88%
1
2
3
4
5
6
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
17
Поделиться
Цитировать
ГОСТ |
Цитировать
Pagliano P. et al. The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19) // Expert Opinion on Drug Discovery. 2022. Vol. 17. No. 12. pp. 1-13.
ГОСТ со всеми авторами (до 50) Скопировать
Pagliano P., Sellitto C., Ascione T., Scarpati G., Folliero V., Piazza O., Franci G., Filippelli A., Conti V. The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19) // Expert Opinion on Drug Discovery. 2022. Vol. 17. No. 12. pp. 1-13.
RIS |
Цитировать
TY - JOUR
DO - 10.1080/17460441.2022.2153828
UR - https://doi.org/10.1080/17460441.2022.2153828
TI - The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)
T2 - Expert Opinion on Drug Discovery
AU - Pagliano, Pasquale
AU - Sellitto, Carmine
AU - Ascione, Tiziana
AU - Scarpati, Giuliana
AU - Folliero, Veronica
AU - Piazza, Ornella
AU - Franci, Gianluigi
AU - Filippelli, Amelia
AU - Conti, Valeria
PY - 2022
DA - 2022/12/12
PB - Taylor & Francis
SP - 1-13
IS - 12
VL - 17
PMID - 36508255
SN - 1746-0441
SN - 1746-045X
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2022_Pagliano,
author = {Pasquale Pagliano and Carmine Sellitto and Tiziana Ascione and Giuliana Scarpati and Veronica Folliero and Ornella Piazza and Gianluigi Franci and Amelia Filippelli and Valeria Conti},
title = {The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)},
journal = {Expert Opinion on Drug Discovery},
year = {2022},
volume = {17},
publisher = {Taylor & Francis},
month = {dec},
url = {https://doi.org/10.1080/17460441.2022.2153828},
number = {12},
pages = {1--13},
doi = {10.1080/17460441.2022.2153828}
}
MLA
Цитировать
Pagliano, Pasquale, et al. “The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19).” Expert Opinion on Drug Discovery, vol. 17, no. 12, Dec. 2022, pp. 1-13. https://doi.org/10.1080/17460441.2022.2153828.